ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Sr Director/Executive Director, CDOS Process Owner at Eli Lilly and Company - ApplyBlast

Sr Director/Executive Director, CDOS Process Owner

Eli Lilly and Company

3 months ago

4.0 on Glassdoor

Indianapolis, Indiana, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Sr Director/Executive Director, CDOS Process Owner leads the end‑to‑end design, management and continuous improvement of global clinical development processes within Lilly's Clinical Trial Foundations. This role partners with cross‑functional leaders, ensures compliance and efficiency, and drives automation and process optimization to accelerate the delivery of medicines.

Responsibilities

Define and design end-to-end clinical processes
Lead cross-functional project teams for process improvement
Establish process controls and continuous improvement agenda
Collaborate with stakeholders to ensure compliance and inspection readiness
Recruit, develop, and manage process ownership team

Skills

Qualifications

Bachelor's DegreeMaster's DegreeDoctorateSix Sigma Black BeltSix Sigma Green Belt

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.